Chemotherapy resistance and oncogene expression in non–small cell lung cancer-Reference-Cited by-同舟云学术

Chemotherapy resistance and oncogene expression in non–small cell lung cancer

Published:2007-02 Issue:2 Volume:133 Page:352-363
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

d‘Amato Thomas A.,Landreneau Rodney J.,Ricketts William,Huang Weidong,Parker Ricardo,Mechetner Eugene,Yu Ing-Ru,Luketich James D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference34 articles.

1. American Cancer Society cancer facts and figures 2006,2006

2. Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer;N Engl J Med,2004

3. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) Protocol 9633;Strauss;J Clin Oncol,2004

4. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10;Winton;N Engl J Med,2005

5. ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): final results after 70-month median follow-up;Douillard;J Clin Oncol,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients: A Field Synopsis and Meta‐Analysis;British Journal of Biomedical Science;2024-02-21

2. Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer;Molecular Biology Reports;2024-01-13

3. Recent advances in functional bismuth chalcogenide nanomaterials: Cancer theranostics, antibacterial and biosensing;Coordination Chemistry Reviews;2023-10

4. Molecular biology of microRNA-342 during tumor progression and invasion;Pathology - Research and Practice;2023-08

5. Remodeling tumor microenvironment with natural products to overcome drug resistance;Frontiers in Immunology;2022-11-10